Speakers Articles

Take a look at what some of our invited speakers have published recently and chat with them about their work in Berkeley at our symposium.

Keynote Speakers

Shinya Yamanaka & Kazutoshi Takahashi
A developmental framework for induced pluripotency ​

Shinya Yamanaka & Kevin Eggan
10 Questions: Clinical Outlook for iPSCs

Rudolf JaenischWhitehead Institute, USA
Induced Pluripotent Stem Cells Meet Genome Editing
Tracing Dynamic Changes of DNA Methylation at Single-Cell Resolution


Kristin Baldwin
The Complete Genome Sequences, Unique Mutational Spectra, and Developmental Potency of Adult Neurons Revealed by Cloning

Juan Carlos Izpisua Belmonte
Selective elimination of mitochondrial mutations in the germline by genome editing 
Dynamic Pluripotent Stem Cell States and Their Applications

Juan Carlos Izpisua BelmonteNissim Benvenisty & Lorenz Studer
Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders

Nissim Benvenisty
Derivation and differentiation of haploid human embryonic stem cells
Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects

George Daley
Dissecting Engineered Cell Types and Enhancing Cell Fate Conversion via CellNet 
Effect of Developmental Stage of HSC and Recipient on Transplant Outcomes

Hongkui Deng
A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming
Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons
Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications

Sheng Ding
Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts
Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Kevin Eggan
Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus
From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial

Sandra Engle
Integrating human pluripotent stem cells into drug development

Guo-li Ming
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth

Christine Mummery
SnapShot: Key Advances in hiPSC Disease Modeling
Complex Tissue and Disease Modeling using hiPSCs

Kathrin Plath
X chromosome reactivation in reprogramming and in development
X Chromosome Reactivation Dynamics Reveal Stages of Reprogramming to Pluripotency

Hans Schöler
Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs

Deepak Srivastava
Human Disease Modeling Reveals Integrated Transcriptional and Epigenetic Mechanisms of NOTCH1 Haploinsufficiency 
Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses

Lorenz Studer
Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease
Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency

Marius Wernig
Inhibition of Pluripotency Networks by the Rb Tumor Suppressor Restricts Reprogramming and Tumorigenesis

Supporting Publications
Premier Sponsor
Gold Sponsor
Silver Sponsor
  • Benchling
  • Reprocell
  • Takeda
  • 89 North
  • Baker Ruskinn
  • BioInformant
  • Chroma
  • Hello Bio
  • Alpha Med Scientific
  • Axion Biosystems
  • biolamina
  • biolamina
  • kcoi
  • Matrixome
  • Peprotech
  • Clontech
  • WiCell